163 related articles for article (PubMed ID: 2105274)
1. Involvement of gamma interferon in antibody enhancement by adjuvants.
Odean MJ; Frane CM; Van derVieren M; Tomai MA; Johnson AG
Infect Immun; 1990 Feb; 58(2):427-32. PubMed ID: 2105274
[TBL] [Abstract][Full Text] [Related]
2. T cell and interferon-gamma involvement in the adjuvant action of a detoxified endotoxin.
Tomai MA; Johnson AG
J Biol Response Mod; 1989 Dec; 8(6):625-43. PubMed ID: 2513379
[TBL] [Abstract][Full Text] [Related]
3. Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens.
Audibert FM; Przewlocki G; Leclerc CD; Jolivet ME; Gras-Masse HS; Tartar AL; Chedid LA
Infect Immun; 1984 Jul; 45(1):261-6. PubMed ID: 6735468
[TBL] [Abstract][Full Text] [Related]
4. [Enhancement of the activity of hepatitis B virus vaccine by association with murabutide].
Audibert F; Przewlocki G; Lefrancier P; Choay J; Chedid L
C R Seances Acad Sci III; 1982 Nov; 295(10):611-4. PubMed ID: 6218866
[TBL] [Abstract][Full Text] [Related]
5. The muramyl dipeptide analog GMTP-N-DPG preferentially induces cellular immunity to soluble antigens.
Fast DJ; Vosika GJ
Vaccine; 1997 Nov; 15(16):1748-52. PubMed ID: 9364678
[TBL] [Abstract][Full Text] [Related]
6. Differential role of interferon-gamma in the potentiating effect of muramyl peptides for enhanced responses to lipopolysaccharide in mice: effect of cyclosporin A.
Beigneux A; Huang J; Le Contel C; Heremans H; Parant MA
J Interferon Cytokine Res; 1995 Apr; 15(4):359-65. PubMed ID: 7627811
[TBL] [Abstract][Full Text] [Related]
7. Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen, Mo3e.
Todd RF; Alvarez PA; Brott DA; Liu DY
J Immunol; 1985 Dec; 135(6):3869-77. PubMed ID: 3934269
[TBL] [Abstract][Full Text] [Related]
8. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine.
Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT
Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
10. Polyadenylic: polyuridylic acid-induced determinants of host resistance to cytomegalovirus and their potentiation by hyperthermia.
Lee BK; Mohrman M; Odean MJ; Johnson AG; Morin A; Deschamps de Paillette E
J Immunother (1991); 1992 Aug; 12(2):105-14. PubMed ID: 1324000
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramylpeptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):19-26. PubMed ID: 3702542
[TBL] [Abstract][Full Text] [Related]
12. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
Nagao S; Sato K; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):999-1002. PubMed ID: 3142490
[TBL] [Abstract][Full Text] [Related]
13. Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies.
Bahr GM; Tello DS; Chedid LA
Infect Immun; 1985 Aug; 49(2):312-9. PubMed ID: 4018873
[TBL] [Abstract][Full Text] [Related]
14. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
[TBL] [Abstract][Full Text] [Related]
15. Effect of a synthetic adjuvant on the induction of primary immune responses in T cell-depleted spleen cultures.
Watson J; Whitlock C
J Immunol; 1978 Jul; 121(1):383-9. PubMed ID: 307582
[TBL] [Abstract][Full Text] [Related]
16. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
[TBL] [Abstract][Full Text] [Related]
17. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.
Carelli C; Audibert F; Chedid L
Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms.
Metzger DW; McNutt RM; Collins JT; Buchanan JM; Van Cleave VH; Dunnick WA
Eur J Immunol; 1997 Aug; 27(8):1958-65. PubMed ID: 9295032
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
Löwy I; Leclerc C; Bourgeois E; Chedid L
J Immunol; 1980 Jan; 124(1):320-5. PubMed ID: 6985643
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of interferon-induced indoleamine 2,3-dioxygenase in human macrophage cultures by lipopolysaccharide, muramyl tripeptide, and interleukin-1.
Hissong BD; Byrne GI; Padilla ML; Carlin JM
Cell Immunol; 1995 Feb; 160(2):264-9. PubMed ID: 7720088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
